Structure-Based Optimization and Biological Evaluation of SARS-CoV-2 3CLpro Covalent Inhibitors

Nicolas, Moitessier, Guanyu, Wang, Julia, Stille, Richard, Boulon, Christopher, Hennecker, Xiaocong, Zhang, Nicole, Blaine, Steven, Laplante, Anthony, Mittermaier
{"title":"Structure-Based Optimization and Biological Evaluation of SARS-CoV-2 3CLpro Covalent Inhibitors","authors":"Nicolas, Moitessier, Guanyu, Wang, Julia, Stille, Richard, Boulon, Christopher, Hennecker, Xiaocong, Zhang, Nicole, Blaine, Steven, Laplante, Anthony, Mittermaier","doi":"10.26434/chemrxiv-2024-091mt","DOIUrl":null,"url":null,"abstract":"The global emergence of COVID-19, caused by SARS-CoV-2, has underscored the critical need for effective antivirals against coronaviruses. The 3-chymotrypsin-like protease (3CLpro) of coronavirus has been a primary target for drug development due to its critical role across various coronaviruses. Following our initial report, this study focuses on the structure-based optimization of 3CLpro covalent inhibitors. With the guidance of molecular docking and covalent binding parameters measured from an innovative isothermal titration calorimetry-kinetic competition (ITC-KC) assay, we optimized and synthesized series of potent covalent inhibitors with antiviral activity in cell-based assays.","PeriodicalId":9813,"journal":{"name":"ChemRxiv","volume":"91 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ChemRxiv","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26434/chemrxiv-2024-091mt","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The global emergence of COVID-19, caused by SARS-CoV-2, has underscored the critical need for effective antivirals against coronaviruses. The 3-chymotrypsin-like protease (3CLpro) of coronavirus has been a primary target for drug development due to its critical role across various coronaviruses. Following our initial report, this study focuses on the structure-based optimization of 3CLpro covalent inhibitors. With the guidance of molecular docking and covalent binding parameters measured from an innovative isothermal titration calorimetry-kinetic competition (ITC-KC) assay, we optimized and synthesized series of potent covalent inhibitors with antiviral activity in cell-based assays.
基于结构的 SARS-CoV-2 3CLpro 共价抑制剂优化与生物学评估
由 SARS-CoV-2 引起的 COVID-19 在全球范围内的出现,凸显了对冠状病毒有效抗病毒药物的迫切需要。由于冠状病毒的 3-糜蛋白酶样蛋白酶(3CLpro)在各种冠状病毒中的关键作用,它一直是药物开发的主要目标。继我们最初的报告之后,本研究侧重于基于结构优化 3CLpro 共价抑制剂。在分子对接和创新性等温滴定量热动力学竞争(ITC-KC)测定法测得的共价结合参数的指导下,我们优化并合成了一系列在基于细胞的实验中具有抗病毒活性的强效共价抑制剂。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信